US Patent 7186802 Claudin polypeptides
Patent 7186802 was granted and assigned to Immunex on March, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+270 characters)
Article
Patent abstract
This invention relates to new members of the human Claudin polypeptide family, to methods of making such polypeptides, and to methods of using them to treat Claudin-associated conditions and to identify compounds that alter Claudin polypeptide activities.
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07186802 Claudin polypeptides US Patent 7186802 Claudin polypeptides
Infobox
Patent Number
0718680200
Patent Number
718680200
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 29 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071868020
Date of Patent
March 6, 2007
0Patent Application Number
103444870
Date Filed
August 15, 2001
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071868020
Date of Patent
March 6, 2007
0Patent Application Number
103444870
Date Filed
August 15, 2001
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 20 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07186802 Claudin polypeptides
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07186802
Date of patent
March 6, 2007
Patent application number
10344487
Date Filed
August 15, 2001
Patent primary examiner
Find more entities like US Patent 7186802 Claudin polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
